Adela

adelabio.com

Adela develops innovative and accessible technologies focusing on the detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test. Adela’s genome-wide methylome enrichment platform captures information efficiently from the entire methylome. Its technology distinguishes the most highly informative (methylated) regions of the genome from non-informative regions and preferentially targets those regions for sequencing.